SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Medical - Healthcare >

Axxess Pharma, Inc. (AXXE)

Add AXXE Price Alert      Hide Sticky   Hide Intro
Moderator: malc stone
Search This Board: 
Last Post: 4/19/2017 8:13:07 AM - Followers: 141 - Board type: Free - Posts Today: 0


   AXXESS PHARMA INC.   Axxess Pharma Inc.



 We are the specialty pharmaceutical company

We pride ourselves in providing cost-effective therapeutic options for patients, especially in underserved disease segments.

Over the Counter and prescription products will be introduced in Canada and other countries. Prescription products will consist of specialized medicines with few competitors.

Our 23 wholly-owned prescription and non-prescription products are targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability. Our company will continue to tap the well of innovation to develop ever-more effective and affordable treatment options for the patients we serve, and also foster innovation in education, leadership and advocacy.

Personal passion concerning the well-being of chronic illness sufferers is a major driving force and at the heart of our company. Affordable, proven, prescription and non-prescription products are a critical component to our company Business Plan. We balance environmental impact, social contribution, and financial results. Axxess Pharma is publicly traded on the US stock exchange under the ticker symbol: AXXE . Headquartered in Canada, AXXE is a specialty pharmaceutical and nutritional supplements company, that works through its wholly owned subsidiary, AllStar Health Brands Inc.                           


A wholly-owned subsidiary of Axxess Pharma Inc., with the licensed world-wide rights to manufacture, and distribute TapouT-branded line of Pain relief, Vitamins & Minerals and Nutritional Supplements.




 New line to be sold through military exchanges 
 MarketWatch: Partnership with Axxess Pharma Inc.

"This is the culmination of more than a year's hard work and we are extremely grateful to Acosta, one of the largest US distributors for making this happen," stated Dr. Daniel Bagi, President of Axxess Pharma. "The Army and Air Force (AAFES) have 2,817 facilities in 30 countries, all fifty states and five US territories. These worldwide facilities include embassies and small bases where we have troops stationed-like in Sarajevo. Retail sales in their stores last year reached $9.2 Billion."

AllStar Health Brands expects TapouT products to be well-received on military bases as the TapouT brand is popular with military personnel who embrace the toughness and dedication the brand represents.                                                                         

Axxess Pharma Announces Expansion of US Sales Channels

Receives Initial Purchase Order From


TapouT Vitamins                                                                   





Gravergol® Anti-Migraine Therapy. Gravergol Anti-Migraine Therapy


Gravergol® remains the only prescription product in Axxess Pharma’s lineup of medicines. Gravergol® acts on both the pain as well as the nausea and vomiting of migraine headaches. While Gravergol® competes in a large category with well-known brands such as Imitrex® and Zomig®, Gravergol® is available at one tenth of the price of aforementioned products. Over 20 million prescriptions have been written for Gravergol®

This is testament to the product’s efficacy and safety.

 Prior to the discontinuation of Gravergol® in 2009, Gravergol® was selling approximately $200k MAT.

The market size of the ergot-derivative market is estimated to be approximately $2MM.   




 Triferexx®150 mg

Triferexx®150 mg

Triferexx®was the flagship product for Axxess Pharma prior to the company entering receivership in 2009. Triferexx® was responsible for +90% of Axxess Pharma’s sales and will be re-launched as a natural health product (NHP) once Health Canada re-issues the license in 2014. Triferexx® 150 mg is a high potency (150 mg elemental oral iron) supplement. Triferexx® 150 allows for once-daily dosing while minimizing side effects such as constipation, diarrhea, upset stomach and other GI side effects which other iron supplements such as ferrous saltsmay cause. Triferexx® 150 avoids or reduces these common side effects.

The types of patients which are candidates for Triferexx® are:

• Patients suffering from blood loss  • Pregnant women  • Women who experience heavy menstrual bleeding  • Renal failure patients, especially those undergoing dialysis • Patients suffering from low iron as a results of a disease


Triferexx® will be sold in Canada and Mexico commencing January, 2014.



                                                      Soropon® OTC Fungal Shampoo


Soropon®is an antifungal Shampoo which was selling approximately $600k MAT under previous management. Soropon® shampoo is a gentle, effective treatment for fungal infections of the scalp such as sebhorreic dermatitis and cradle cap in infants

The main competitors for Soropon® are Nizoral®, Dan-Guard®, SebCur®and Polytar®. The price range for products in this market are $20.00 - $24.00. The estimated market size of this category is $10MM.

Cancer Drugs Portfolio

AXXESS has entered into an exclusive distribution agreement with the Canadian manufacturer of a full line of approximately 12 cancer drugs for injection, and a suite of other antibiotic drugs for injection.


Biolyse Corporation, the Canadian manufacturer of this common cancer drug used in the treatment of several major cancers including breast, lung, ovarian and several others has granted the rights for Mexico and other Latin American territories to Axxess Pharma.

The key driver to the success of this business for Axxess Pharma is the price point, and Axxess has obtained a favorable price in order to compete in Mexico and other Latin American territories.

The sale of cancer drugs in the majority of Latin American markets is primarily through government tenders due to the relatively high prices of most cancer drugs. 

Axxess has already an agreement in place to work with a company in Mexico with experience in government tender business and has the advantage of offering a high-quality Canadian product at a price competitive with local manufacturers and as part of the North American Free Trade Agreement is legally allowed to enter into the tender business.

Axxess expects to add up to 11 other cancer drugs to this portfolio as they become available from the Canadian manufacturer, including the expected first generic version of a major cancer drug which currently enjoys sales in Mexico of approximately US $20 MM.



Nutritional Products International (NPI) , who handles the United States distribution for the company is excited to begin branching out the full TapouT Sports Nutrition line.                                 NPI has the ability to reach thousands of retail outlets across the United States. The company also exports products to all seven continents.

"With TapouT Sports Nutrition products, we see nothing that can stop these products from becoming an even bigger household name than they already are," says NPI CEO, Mitch Gould. "We fully believe this line will be a huge success. If these products are good enough for some of the hardest training athletes in the world, then they will do wonders for everyone who uses them."
  Revive BioScience Inc. a leader in developing private label pain relief products, for leading consumer brands and health care organizations. Revive offers a full range of pain relief products including:  
•OTC Analgesic products
• OTC Topical analgesic products
• All natural pain relief supplements
• Hot & Cold Therapy products

Revive has a national distribution of products in Canada, through GNC and independent retail stores, and expects to add other large retail outlets later this year. The products Revive developed will be sold in mass retail stores across Canada (currently in market), USA and Mexico.

Further, the company has an exclusive world-wide license with one of the top sporting brands in the world. This license provides access to a global distribution network, including 20,000+ retailers. The branded products are endorsed by current athletes from the NFL, NHL and UFC.

Revive also brings a number of key operators to Axxess Pharma with extensive experience in retail and online sales. This will benefit all of the products now controlled by Axxess Pharma.

Dr. Daniel Bagi, President of Axxess Pharma Inc., stated: "We are extremely pleased and excited to announce this acquisition of Revive. Both sides have been working long and hard to finalize this acquisition, which will instantly add revenues to Axxess Pharma's bottom line. We believe we can very quickly grow sales significantly working with Revive's team through added marketing efforts. They have great products which are widely recognized. We expect this acquisition will facilitate access to capital and enable a rapid ramp-up of sales for major revenue growth in the near term."

For more information, please visit, or contact Investor Relations at (973) 351-3868.       
Recently AXXE announced that with its strategic partner, Vortex Traffic LLC, there will bea nation-wide mass online launch of TapouT Muscle Explosion. Since 2007 Vortex has produced over $140 million in global sales for its clients!  
The target has isolated over 4,500 websites to launch the campaign on!
Stephen Blazick, President of Vortex Traffic LLC, stated: "TapouT continues to be Vortex's primary focus due to its scalability potential and is unlike any other partnership we have had. Our team at Vortex is target-focused on launch by mid-February and have isolated over 4,500 web sites we are planning to launch this campaign on. It will be a household name, if it is not already, within months."

AXXE has also been adding celebrity athletes on as endorsers, recently including Catia James, a cross-fit bikini competiton champion, and champion bodybuilder Michael Spencer. 


 Axxess Pharma Inc. (AXXE) - VNN - Daniel Bagi MD Published on Jun 27, 2013

VNN discovers the exciting things happening within Axxess Pharma Inc. as they assemble a talented team, re-launch products and launch pain relief through the TAPOUT brand.
    Axxess Pharma Inc. poised for immediate revenue:

  • Goals – to reach $36 million year 4
    Product mass retail across North America
    Worldwide online sales distribution

World-wide exclusive license with TapouT® brand

  • World leading athletic lifestyle brand - w/$350MM/yr.

Management: Proven track record, highly experienced 

2013 - 2015  Forecast                            Product Overview

Axxess has a wide range of specialized healthcare products. Products will be launched based on priority and market demand.

Specialized products include:

  • Specialized vitamins
    All natural pain relief
    Diabetes-specific supplements
    Pain relief supplements
    Hot/cold therapy

           Interview with Axxess Pharma Inc (AXXE)      


 OTC Pink Current Information            Common Stock AXXE Axxess Pharma, Inc. 

Contact Info

 Share Structure
Market Value    
Shares Outstanding    
Authorized Shares 3,000,000,000   






Revive Bioscience Retracts Press Release of Jun 24, 2014


Revive Bioscience states that it will not rescind the Axxess Pharma Inc. Asset Purchase Agreement, following the successful resolution of certain undisclosed and outstanding items. Revive recognizes Axxess Pharma Inc. ownership of the TapouT license, products and related patents. Axxess Pharma Inc. has achieved remarkable strides in the marketing of existing products and the development of a new product line. We clearly see the long-term potential and benefits of our current alliance with Axxess Pharma Inc., and support all of their efforts.



Make sure to read through all of the company's news!

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#11170   500 million in volume Trucavss 04/19/17 08:13:06 AM
#11169   I just realized the volume.... wow Trucavss 04/19/17 01:39:23 AM
#11168   Yea? Nysilverfox 04/18/17 06:28:48 PM
#11167   Coil baby coil AXXe is about to FLY RSI38 04/18/17 03:41:32 PM
#11166   500mm in volume?! Nysilverfox 04/18/17 10:11:49 AM
#11165   A lot of volume today Nysilverfox 04/18/17 09:57:12 AM
#11164   Maybe maybe not. I only have 2 Trucavss 04/17/17 04:56:58 PM
#11163   I wander if there will ever be any Chrisny73 04/06/17 08:05:56 PM
#11162   Lol. Well we just have to Trucavss 04/06/17 08:04:30 PM
#11161   1 sold share and 3 in the black... Nysilverfox 04/06/17 08:03:25 PM
#11159   Look at that paint back up to .0002 malc stone 03/31/17 04:24:40 PM
#11158   Thanks Trackk so much RSI38 03/31/17 01:18:09 PM
#11157   Been out of this for awhile. No desire trackkwizzard 03/31/17 01:08:21 PM
#11156   Hi Trackk,, RSI38 03/31/17 12:40:58 PM
#11155   Uh huh. Look at the ole AXXE chop down malc stone 03/31/17 12:39:03 PM
#11154   2s are looking thinner CrazyKar123 03/30/17 05:21:59 PM
#11153   Hoping they carry over to Axxe as well.. Nysilverfox 03/29/17 12:27:23 AM
#11152   Gelmon has good things in the works KSEAVER 03/29/17 12:02:30 AM
#11151   Gelmon appears to be the president or CEO Nysilverfox 03/28/17 02:14:16 PM
#11150   Looks to be so Trucavss 03/28/17 01:08:34 PM
#11149 trackkwizzard 03/28/17 12:47:07 PM
#11148   4bil AS is not bad. This will fly poorguy1 03/26/17 12:47:26 PM
#11147   are we making profit ore stil losing missing news. emailcheque 03/24/17 02:20:10 PM
#11146   Thx for sharing information , it seems they Gigi70 03/24/17 03:29:53 AM
#11145   A/S Increase to 4 BILLION shares per NVSOS Filing DaReal 03/24/17 03:18:56 AM
#11144   3's would be excellent Nysilverfox 03/23/17 03:29:50 PM
#11143   Me too :) Trucavss 03/23/17 03:22:36 PM
#11142   waiting for 0,0003 emailcheque 03/23/17 03:20:46 PM
#11141   All the trades to appear to be sell trades... Nysilverfox 03/23/17 02:16:55 PM
#11140   I did some reading on $NOHO and it Trucavss 03/22/17 05:01:39 PM
#11139   Nice, I'll take a look Nysilverfox 03/20/17 09:48:48 AM
#11138   Checkout NOHO it's got some of the players/CEO KSEAVER 03/20/17 09:46:32 AM
#11137   I hear ya there.. looking forward to Nysilverfox 03/19/17 10:56:17 PM
#11136   Let's keep our fingers crossed for this week. Trucavss 03/19/17 10:55:21 PM
#11135   Have a great weekend everyone.. looking forward to Nysilverfox 03/17/17 05:23:58 PM
#11134   I agree. Maybe some news will Trucavss 03/17/17 04:41:48 PM
#11133   I just want to see progress each week.. Nysilverfox 03/17/17 04:40:43 PM
#11132   Me too me too. Lets do Trucavss 03/17/17 04:36:16 PM
#11131   Hoping next week is a solid week.. Nysilverfox 03/17/17 04:35:12 PM
#11130   How soon do you think? Trucavss 03/17/17 04:32:36 PM
#11129   200k shares bought right after the 1mm dump.. Nysilverfox 03/17/17 04:03:46 PM
#11128   Someone just dumped 1mm shares Nysilverfox 03/17/17 03:54:57 PM
#11127   I do believe we are ready for .0003 Nysilverfox 03/17/17 01:25:54 PM
#11126   I wish Trucavss 03/17/17 01:05:24 PM
#11125   It's ready for .0003 CrazyKar123 03/17/17 12:15:14 AM
#11124   That was a good chuckle. Let's see now kbrod1 03/15/17 11:25:28 AM
#11123   Shorts? LOL. The POS serial dilution malc stone 03/14/17 04:38:27 PM
#11122   Anyone think they are buying back or are RFL1969 03/14/17 01:52:27 PM
#11121   No problem. malc stone 03/13/17 07:33:26 PM
#11120   Gracias Nysilverfox 03/13/17 07:29:25 PM